RegCell secures funding and completes US headquarters transition

RegCell opens up cell therapy shop in California with $45M in funding

A Japanese biotech founded by Treg cell discoverer moves to the US with $45.8M

Japan’s Regcell launches in US with $45.8M to advance Treg platform

Japanese-Founded Regulatory T-cell Reprogramming Company RegCell Secures $45.8M in Funding and Completes U.S. Headquarters Transition

RegCell Appoints Leading T-Cell Therapy Expert Steven B. Kanner, Ph.D., to Board of Directors

Chutes & Ladders—Google DeepMind vet to join GSK as VP of artificial intelligence

Co-founded by David Baker, Vilya rings in a permanent CEO; Allogene names Eric Schmidt’s CFO successor

Up and down the ladder: The latest comings and goings

RegCell Appoints Experienced Life Science Executive and Entrepreneur Michael McCullar, Ph.D., MBA, as its New Chief Executive Officer

RegCell Hires Michael McCullar as CEO

RegCell Appoints Experienced Life Science Executive and Entrepreneur Michael McCullar, Ph.D., MBA, as its New Chief Executive Officer